Clinical Trials Browser

Phase 1 × Neuroblastoma × Immunohistochemistry × Clear all

NCT00492167 2022-03-07

Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma

Phase 1 Completed

Neuroblastoma